文献速递头颈技术与安全CTPET

分化型甲状腺癌患者放射性碘闪烁显像假阳性结果的图谱综述

Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer.
PubMed 文献 · Radiographics · 2017-01-01

本文以图谱综述形式阐述放射性碘的生理与生物分布,并按钠碘同向转运体表达所致功能性摄取、放射性碘滞留、非甲状腺肿瘤、炎症或感染性摄取、污染及其他原因分类展示放射性碘闪烁显像的假阳性结果,结合临床与解剖影像进行关联。文章指出SPECT/CT有助于准确解剖定位和表征假阳性摄取,尤其在血清甲状腺球蛋白低而平面显像阳性的不一致病例中具有增量价值。

要点

  • 放射性碘显像的判读须结合病史、组织病理、实验室检查、解剖影像和体格检查。
  • 理解放射性碘的生理与生物分布是避免将生理性或非甲状腺病变误判为转移的关键。
  • SPECT/CT有助于准确解剖定位和表征假阳性放射性碘摄取。

核心结论

  • 正确区分假阳性与真转移对确定治疗前放射性碘治疗剂量及判断治疗后是否需要重复治疗和随访很重要。

研究设计与样本

  • 本文为图谱综述,按放射性碘摄取原因分类展示假阳性结果并结合临床与解剖影像进行关联,纳入文献未在原文中具体说明。

关键影像表现/征象

  • 放射性碘假阳性可见于钠碘同向转运体表达所致功能性摄取、放射性碘滞留、非甲状腺肿瘤、炎症或感染性摄取、污染及其他原因。

诊断标准与关键数值

  • 原文未报告敏感度、特异度、AUC、阈值或分级标准。

临床应用与阅片要点

  • 判读放射性碘闪烁显像时需结合全面病史、组织病理、相关实验室值、解剖影像及体格检查,以避免将生理性和非甲状腺病理变异误判为甲状腺癌转移。
  • 血清甲状腺球蛋白水平低而放射性碘全身平面显像阳性的不一致病例中,SPECT/CT对假阳性摄取的准确解剖定位和表征具有增量价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Radioiodine has served an important role in the diagnostic workup and treatment of patients with differentiated thyroid cancer for more than 6 decades. The interpretation of radioiodine scintigraphic studies should be performed in conjunction with a comprehensive history, histopathologic correlation, and pertinent laboratory values, as well as correlation with available anatomic images and the findings from physical examination. A thorough understanding of the physiology and biodistribution of radioiodine is critical when interpreting radioiodine scintigraphic studies to avoid misinterpretation of physiologic and nonthyroid pathologic variants as thyroid cancer metastases. Differentiating a false-positive finding from a true metastasis on pretherapy radioiodine scintigrams is important to determine the appropriate radioiodine treatment dose. The correct interpretation of posttherapy radioiodine scintigraphic studies is also important to determine if repeat radioiodine treatment will be necessary and for the future clinical and imaging followup of the patient. A variety of different factors, such as the presence of the sodium-iodide symporter and the passive diffusion or retention of radioiodine in normal and pathologic structures, can result in false-positive results on radioiodine scintigrams. Numerous false-positive findings have been reported in the literature and are further demonstrated with the increasing availability of single photon emission computed tomography (SPECT) integrated with computed tomography (CT) as true dual-modality imaging (SPECT/CT). SPECT/CT has been documented to be of incremental value in the accurate anatomic localization and characterization of radioiodine uptake as false-positive findings, particularly in cases with discordant findings of a low serum thyroglobulin level but positive findings on radioiodine whole-body planar scintigrams. The objectives of this review are to describe the physiology and biodistribution of radioiodine and to provide examples of false-positive results on radioiodine scintigrams, with clinical and anatomic correlation, in the following categories of radioiodine uptake: functional uptake secondary to sodium-iodide symporter expression, radioiodine retention, nonthyroid neoplasms, inflammatory or infectious uptake, contamination, and other causes. ©RSNA, 2017.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Chudgar AV, Shah JC. Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer. Radiographics. 2017. PMID: 28076008. doi:10.1148/rg.2017160074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。